VYNE Therapeutics Inc. (NASDAQ:VYNE) has 44 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Anson Funds Management LP | 31 Dec, 2025 | 0 | 1,274,386 | 0.00% | $0.00 |
| Shay Capital LLC | 31 Dec, 2025 | 0 | 1,131,772 | 229.77% | $0.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 0 | 1,000,000 | 0.00% | $0.00 |
| T3 Companies, LLC | 31 Dec, 2025 | 0 | 945,000 | 0.00% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 192,078 | 43.03% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 507,582 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 124,162 | 65.22% | $0.00 |
| KVP Capital Advisors, LP | 31 Dec, 2025 | 0 | 500,551 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 88,030 | 64.20% | $0.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 0 | -25,088 | -8.65% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | -788 | -0.36% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 79,040 | 0.00% | $0.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 0 | 106,500 | 188.16% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 57,189 | 1,026.36% | $0.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 0 | 42,578 | 73.71% | $0.00 |
| FNY Investment Advisers, LLC | 31 Dec, 2025 | 0 | 25,000 | 0.00% | $0.00 |
| Rangeley Capital, LLC | 31 Dec, 2025 | 0 | 50,000 | 100.00% | $0.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Dec, 2025 | 0 | -585,147 | -99.76% | $0.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -25,088 | -23.57% | $0.00 |